Disease/Infection News

RSS

TSRI scientists track how HIV-fighting antibodies develop over time

In a new study, a team led by scientists at The Scripps Research Institute tracked how a family of these HIV-fighting antibodies develops over time. The research shows how a future vaccine might trigger the immune system to produce these antibodies more effectively.

16 Dec 2015

Prophylaxis treatment can protect children who receive liver transplants from HBV-infected donors

Researchers have found that a prophylaxis treatment can prevent new-onset hepatitis B in children who receive liver transplants from donors who were previously infected with hepatitis B virus (HBV) but had successfully cleared the virus.

16 Dec 2015

BUSM researchers explore how do not resuscitate orders affect hospital rankings for pneumonia

Researchers from Boston University School of Medicine examined how hospital differences in patient preferences for life-sustaining treatments (do not resuscitate, or DNR, orders) affected hospital rankings for pneumonia.

16 Dec 2015

Molecular signatures can predict flu vaccine responses in young and old

What factors inhibit strong responses to seasonal flu vaccines in the elderly? Why do anti-flu antibodies last longer after vaccination in some people? Answers are emerging from an Emory University-based systems biology analysis of blood samples from more than 400 volunteers who received seasonal flu vaccines. Bali Pulendran, PhD, led a team of researchers who tracked patterns of gene expression, known as molecular signatures, of strong immune responses in volunteers' blood across five consecutive seasons from 2007 to 2011.

16 Dec 2015

TaiGen releases Taigexyn (nemonoxacin) capsules in Taiwan

TaiGen Biotechnology Company, Limited today announced that together with its distribution partner, Holding Distribution, it has launched Taigexyn (nemonoxacin) capsules in Taiwan, the first market where Taigexyn is available.

16 Dec 2015

SLU researcher discovered world's first dengue vaccine

A vaccine to prevent dengue fever discovered by a Saint Louis University researcher in 1997 and now licensed worldwide by Sanofi Pasteur has been approved for use in Mexico. Dengvaxia is the world's first vaccine approved to prevent dengue fever, which is a virus spread by mosquitoes primarily in tropical and sub-tropical areas.

15 Dec 2015

Flu vaccine strategy needs to be reworked, York U study finds

In the face of a flu epidemic, a one-size fits all vaccine strategy won't be effective, a York University study has found. Instead, strategies need to change significantly depending on the characteristics of each region in Canada and how easily the particular flu strain spreads.

15 Dec 2015

Global Health Impact Index can measure actual impact of drugs worldwide

Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.

15 Dec 2015

Researchers discover new way for early detection of potentially deadly fungal infection in leukemia patients

A team of researchers have discovered a new way for early detection of a potentially deadly fungal infection in patients with suppressed immune systems such as those being treated for leukemia or have had an organ transplant.

15 Dec 2015

SLU scientist awarded new $2.2 million NIH grant to develop cure for hepatitis B

With proof-of-principle in his pocket and a new $2.2 million grant from the National Institutes of Health, SLU scientist John Tavis, Ph.D., will take his 25 year mission to finally develop a cure for the hepatitis B virus into the next phase.

15 Dec 2015

Research could lead to new treatments to prevent blockages, urinary tract infections faced by long-term catheter users

New research could lead to new treatments to prevent blockages and urinary tract infections experienced by many long-term catheter users.

14 Dec 2015

Kaiser Permanente bans 'germ-fighting' antimicrobial agents for use in hospitals

Concerned about mounting exposure to toxic chemicals in everyday life and the threat of drug-resistant bacteria, Kaiser Permanente has banned paint and other interior building products treated with "germ-fighting" antimicrobial agents for use in its hospitals and other buildings.

13 Dec 2015

New rapid test can detect malaria parasites, viruses and biomarkers

Nothing could be simpler: a drop of blood is placed on a special carrier substance; after a wait of a few minutes, the slide is placed on a device that emits polarised light thanks to an inexpensive polarisation filter. It is covered with a lid containing a second polarisation filter, which blocks the light from all materials except crystalline or materials with directional properties.

13 Dec 2015

Four journalists from China and India win 2016 EurekAlert! Fellowships for International Science Reporters

Four early-career journalists from China and India have emerged from the fiercest competition to date to win the 2016 EurekAlert! Fellowships for International Science Reporters.

13 Dec 2015

Increasing alcohol taxes decreases gonorrhea rates by 24% in Maryland

Increasing state alcohol taxes could help prevent sexually transmitted infections, such as gonorrhea, according to University of Florida Health researchers, who found that gonorrhea rates decreased by 24 percent in Maryland after the state increased its sales tax on alcohol in 2011.

13 Dec 2015

U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

The United States has sufficient capacity for treating another outbreak of the Ebola virus, but financial, staffing and resource challenges remain a hurdle for many hospitals and health systems attempting to maintain dedicated treatment centers for highly infectious diseases, according to new study released today.

12 Dec 2015

Access to harm reduction programs vey low in rural and suburban areas affected by HIV infections

Access to harm reduction programs such as syringe exchange is lowest in rural and suburban areas, where rates of addiction to heroin and other opioids are on the rise, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

12 Dec 2015

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

In clinical trials, several candidate H7N9 pandemic influenza vaccines made from inactivated viruses have been shown to be safe and to generate an immune response. However, scientists believe for practical use, these potential vaccines would require multiple doses or the addition of adjuvants, which enhance the immune response.

12 Dec 2015

Abbott, UCSF identify human pegivirus 2 among some patients with hepatitis C

Abbott and University of California San Francisco published research identifying a newly discovered human virus, known as human pegivirus 2 (HPgV-2), and proving it is found among some patients with hepatitis C (HCV).

12 Dec 2015

AIDS treatment can improve well-being of HIV-negative people

In rural Malawi, roughly 10 percent of the adult population has HIV. At the peak of the epidemic, in the 1990s and early 2000s, nearly everyone knew someone infected with or affected by the virus, what demographer Hans-Peter Kohler of the University of Pennsylvania describes as a generalized epidemic.

12 Dec 2015

Disease/Infection News

TSRI scientists track how HIV-fighting antibodies develop over time

Prophylaxis treatment can protect children who receive liver transplants from HBV-infected donors

BUSM researchers explore how do not resuscitate orders affect hospital rankings for pneumonia

Molecular signatures can predict flu vaccine responses in young and old

TaiGen releases Taigexyn (nemonoxacin) capsules in Taiwan

SLU researcher discovered world's first dengue vaccine

Flu vaccine strategy needs to be reworked, York U study finds

Global Health Impact Index can measure actual impact of drugs worldwide

Researchers discover new way for early detection of potentially deadly fungal infection in leukemia patients

SLU scientist awarded new $2.2 million NIH grant to develop cure for hepatitis B

Research could lead to new treatments to prevent blockages, urinary tract infections faced by long-term catheter users

Kaiser Permanente bans 'germ-fighting' antimicrobial agents for use in hospitals

New rapid test can detect malaria parasites, viruses and biomarkers

Four journalists from China and India win 2016 EurekAlert! Fellowships for International Science Reporters

Increasing alcohol taxes decreases gonorrhea rates by 24% in Maryland

U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

Access to harm reduction programs vey low in rural and suburban areas affected by HIV infections

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

Abbott, UCSF identify human pegivirus 2 among some patients with hepatitis C

AIDS treatment can improve well-being of HIV-negative people

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News